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Genetic Control of Individual Differences
in Gene-Specific Methylation in Human Brain
Dandan Zhang,1,4 Lijun Cheng,1,4 Judith A. Badner,1 Chao Chen,1 Qi Chen,1 Wei Luo,1
David W. Craig,3 Margot Redman,3 Elliot S. Gershon,1,2 and Chunyu Liu1,*
We have observed extensive interindividual differences in DNA methylation of 8590 CpG sites of 6229 genes in 153 human adult cere-
bellum samples, enriched in CpG island ‘‘shores’’ and at further distances from CpG islands. To search for genetic factors that regulate
this variation, we performed a genome-wide association study (GWAS) mapping of methylation quantitative trait loci (mQTLs) for the
8590 testable CpG sites. cis association refers to correlation of methylation with SNPs within 1 Mb of a CpG site. 736 CpG sites showed
phenotype-wide signiﬁcant cis association with 2878 SNPs (after permutation correction for all tested markers and methylation pheno-
types). In trans analysis of methylation, which tests for distant regulation effects, associations of 12 CpG sites and 38 SNPs remained
signiﬁcant after phenotype-wide correction. To examine the functional effects of mQTLs, we analyzed 85 genes that were with genet-
ically regulated methylation we observed and for which we had quality gene expression data. Ten genes showed SNP-methylation-
expression three-way associations—the same SNP simultaneously showed signiﬁcant association with both DNA methylation and
gene expression, while DNA methylation was signiﬁcantly correlated with gene expression. Thus, we demonstrated that DNA methyl-
ation is frequently a heritable continuous quantitatively variable trait in human brain. Unlike allele-speciﬁc methylation, genetic poly-
morphisms mark both cis- and trans-regulatory genetic sites at measurable distances from their CpG sites. Some of the genetically
regulated DNA methylation is directly connected with genetically regulated gene expression variation.Introduction
Changes of DNA methylation at CpG dinucleotides are
heritable and play an important role in gene expression,
X chromosome inactivation, parental imprinting, develop-
ment, and complex disease.1–3 However, the regulation of
DNA methylation of speciﬁc genes is poorly understood.
A pilot study of the Human Epigenome Project (HEP)
showed that there is considerable interindividual varia-
tion in DNA methylation, with ~50% of CpG sites having
greater than 50% variation across all samples.4 Several
other studies also documented individual CpG sites that
exhibit variation among individuals.5–7
A twin study showed that within the H19 differentially
methylated region (DMR), the heritability of methylation
of individual CpG sites ranged from 20% to 74%. For the
Insulin-like growth factor 2 (IGF2, [MIM 147470]) DMR,
heritability among CpG sites varied between 57% and
97%.6 Bjornsson and colleagues observed that intraindi-
vidual DNA methylation changed over time and that
this variation over time may be under genetic control.2
Furthermore, there exists compelling evidence for several
associations between genetic variants and DNA methyla-
tion of speciﬁc genes. For example, SNP genotypes of the
IGF2/H19 locus, where degree of methylation is involved
in male infertility,8 were found to be signiﬁcantly associ-
ated with methylation of the IGF2 DMR.6 Allele-speciﬁc
methylation (ASM) was demonstrated in 16 SNPs from
a genome-wide study, meaning that one SNP allele was
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The Amerition of a nearby CpG site, and the other allele was associ-
ated with the complete unmethylated state, or the SNP
itself destroyed a CpG site by changing the C or G.9
All these ﬁndings led to the hypothesis that a consider-
able proportion of CpG sites may be quantitative traits
with regulation by speciﬁc genetic variants. Identiﬁcation
of genetic variants that are associated with gene-speciﬁc
DNA methylation could open a new venue to the under-
standing of methylation regulation.
In order to test the feasibility of genetic mapping of
factors regulating DNA methylation, we performed a
genome-wide association study (GWAS) testing associa-
tions between SNP genotypes and DNA methylation of
individual CpG sites by treating methylation as a quantita-
tive trait. This search is not limited to SNPs close to the
CpG sites, which ASM normally targets. We include here
genetic variants that can be hundreds of thousands of
base pairs away or on a different chromosome. DNAmeth-
ylation is controlled by various additional factors and can
be tissue speciﬁc. We elected to study methylation control
in cerebellum of human adult brain.Material and Methods
We obtained 164 human cerebellum samples from the Stanley
Medical Research Institute (SMRI). Of these, 153 individuals of
European ancestry were included in the current analysis. The
brains were autopsy specimens from patients with various psychi-
atric disorders and normal controls. Diagnoses of patients and
unaffected controlswere based on structured interviews by a seniorChicago, Chicago, IL 60637, USA; 2Department of Human Genetics, The
esearch Institute, Phoenix, AZ 85004, USA
Genetics. All rights reserved.
can Journal of Human Genetics 86, 411–419, March 12, 2010 411
psychiatrist with family member(s), to establish or rule out axis I
diagnoses.10–12 The diagnoses were made by two senior psychia-
trists, who used DSM-IV criteria.13 All samples have age, gender,
race, postmortem interval (PMI), brain pH, smoking and alcohol
use, suicide status, and psychotic features data. The sample demo-
graphic data and covariates are summarized in Table S1 available
online.Genotyping Methods
Genomic DNA was extracted from frozen cerebellar tissues
provided by the SMRI. A phenol/chloroform/isoamyl alcohol
protocol was modiﬁed and followed. The DNA was resuspended
in 0.1 mM EDTA TE buffer. Genomic DNAwas evaluated by Nano-
Drop ND-1000 spectrophotometer (NanoDrop Technologies, Wil-
mington, DE) for concentration and by 1% agarose gel to validate
the DNA integrity. We used Affymetrix GeneChip Mapping 5.0K
Array and Assay Kits (Affymetrix, Santa Clara, CA) for genotyping
according to the Affymetrix protocol. Genotypes were called with
the BRLMM-p algorithm (Affymetrix) with all arrays simulta-
neously.
SNPs with call rates R 99%, Hardy-Weinberg equilibrium
(HWE) p values R 0.001, and minor allele frequencies (MAF) R
10% were included in the association tests. Of the genotypes
obtained, 239,834 SNPs passed quality control and were used for
subsequent analyses. Principal component analysis was applied
to verify sample population homogeneity by running EIGEN-
STRAT.14 To examine the relatedness between samples, pair-wise
identity-by-state was calculated with PLINK.15 The results con-
ﬁrmed that the 153 selected samples were unrelated and of Euro-
pean ancestry (see Figures S1–S3).Methylation Assays
Genomic DNA was quantiﬁed by PicoGreen (Invitrogen, CA) and
diluted to a ﬁnal concentration of 50 ng/ml. DNAmethylation was
assessed at the Genomics Core Facility of Northwestern University
(Chicago, IL) with Illumina InﬁniumHumanMethylation27 Bead-
Chips (Illumina Inc., SanDiego, CA). Technical details of this array
are described elsewhere.16 The BeadChip probes 27,578 CpG sites.
Of those, 20,007 sites (72.5%) are located in CpG islands and
7,571 (27.5%) are not. Almost all the sites (97.7%) are located in
‘‘promoter proxy’’ regions (less than 1500 bp from a transcription
start site). Themethylation level of each interrogated CpG site was
calculated as the ratio of signal from a methylated probe relative
to the sum of methylated and unmethylated probes. This
value, b, ranges continuously from 0 (unmethylated) to 1 (fully
methylated).
Pyrosequencing was used to validate DNA methylation data
obtained from Beadchips. Genomic DNA was bisulﬁte converted
according to the protocol in EpiTect 96 Bisulﬁte Kit (QIAGEN)
and used as PCR template. Primers were designed with Pyrose-
quencing Assay Design Software v1.0.6 (Biotage, Uppsala,
Sweden). A full list of primer sequences can be found in
Table S2. PCR ampliﬁcations were performed with a standard
protocol in 25 ml reactions, containing 20 ng of bilsulﬁte-con-
verted DNA, 0.02 mM tagged Primer, 0.2 mM primer, 0.18 mM
universal biotin-labeled primer, 1.0 mM MgCl, 0.125 mM dNTP,
13PCR buffer, and 0.8U Hotstart Taq polymerase (QIAGEN).
PCR cycling conditions are 95C 5 min, 50 cycles (95C 15 s,
60C 30 s, 72C 30 s), and 72C 5 min. PCR products were pro-
cessed according to the manufacturer’s standard protocol (Biot-
age). In brief, 3 ml of streptavidin-sepharose beads (Amersham412 The American Journal of Human Genetics 86, 411–419, March 1Biosciences, Piscataway, NJ) and 40 ml of binding buffer (pH 7.6,
10 mM Tris-HCl, 1 mM EDTA, 2 M NaCl, 0.1% Tween 20) were
mixed with 20 ml of PCR product for 10 min at room temperature.
The reaction mixture was immobilized onto streptavidin-coated
beads. After application of the vacuum, the beads were treated
with high-purity water for 30 s, 70% ethanol for 5 s, and a denatur-
ation solution (0.2 M NaOH) for 5 s and washed for 5 s with
washing buffer (10 mM Tris-acetate at pH 7.6). The beads were
then suspended with 40 ml of annealing buffer (20 mM Tris-
acetate, 2 mM Mg-acetate at pH 7.6) containing 0.5 mM of
sequencing primer, preﬁlled in a PSQ 96 Plate (Biotage). The plate
with samples was heated at 80C for 2 min and ﬁnally cooled to
room temperature. Sequencing reactions were performed with
a PSQ 96 SNP Reagent Kit (Biotage) according to the manufac-
turer’s instructions. The percent methylation at each CpG site
was calculated from the raw data with the Pyro-Q-CpG Software
(Biotage).Classiﬁcation of CpG Sites
More than half of CpG sites assayed (54.3%)were hypomethylated
(%20% DNA methylated; see Figure S4). Studies of HEP data from
three human chromosomes reported a similar pattern of methyla-
tion distribution. CpG sites near promoters were more likely to be
hypomethylated.17,18
A CpG site was studied for SNP association if it had fewer than
95% of individuals with only hypomethylation or only hyperme-
thylation (R80% DNA methylated); 8590 CpG sites were thus
included. Of those, 5097 were not within CpG islands. CpG sites
within 2 kb of CpG islands were deﬁned by Irizarry et al. as
‘‘CpG island shores.’’19 We observed that as compared with CpG
islands, CpG sites with greater variability were enriched both in
‘‘CpG island shores’’ (permutation p value < 1.0E-7) and in more
distant regions (>2 kb from CpG islands, permutation p value <
1.0E-7, see Table S3).
Considering each CpG site for all samples, we generally
observed unimodal (single-peak) distributions. The vast majority
of the included CpG sites (92.7%) had a unimodally distribution,
as observed previously,6,20 lending support to a QTL approach to
genetic analysis rather than a qualitative (binary) locus approach
(Figures S5 and S6).Expression Data
Expression data from cerebellum for 45 of the same individuals is
available from the SMRI Online Genomics Database. Oligonucleo-
tide microarray chip (HGU95Av2) experiments reported in that
database were carried out according to themanufacturer’s protocol
(Affymetrix, Santa Clara, CA).10,12 We performed RMA normaliza-
tion with Partek Genomics Suite (Partek Inc., St. Louis, MO). There
are technical replicates for every individual.10-12 A total of 12,625
probe sets were assayed by HGU95Av2. We selected 4648 probes
that were coded as ‘‘present’’ (called by the Affymetrix Microarray
Suite [MAS] algorithm) in R80% of samples.Expression and Methylation Data Preprocessing
COMBAT21 was used to correct for batch effects within the meth-
ylation and expression array data, including 15 technical replicate
pairs in the methylation data and 45 technical replicate pairs in
the expression data. For later analysis of each technical replicate
pair, the data were averaged for the replicated samples to obtain
a single datum. In order to remove the effects of known and
unknown covariates on the data, surrogate variable analysis2, 2010
(SVA)22 was applied and the identiﬁed surrogate variables were re-
gressed out. We examined the effects of known variables on the
methylation data pre- and post-COMBAT21 and SVA.22 In the
regression analysis, quantitative and categorical covariates were
used according to the data (details in Table S4). The methylation
data before processing demonstrated strong batch effects (barcode
of chips was a signiﬁcant [p < 0.05] covariate for 91% of probes).
Batch effects were present in only 2% of the probes after correc-
tion, which is close to our chance expectation (Table S4). For the
expression data, brain pH and batch effects were signiﬁcant (p <
0.05) in 41% and 10%, respectively, of the probes in the data prior
to preprocessing but each is signiﬁcant in only 1% of the probes in
the corrected data.QTL Analysis
To ﬁt a normal distribution, quantile normalization was used for
both expression andmethylation residuals. Linear regression anal-
ysis was performed to test for correlation between the normalized
residuals and the number of minor alleles via an additive genetic
model by PLINK.15 From this analysis, an asymptotic p value
from the Wald statistic was obtained as a measure of association
of each SNP with methylation of any given CpG site.Multiple Testing Correction
Three sets of permutations of phenotype were performed. Permu-
tations for a CpG-SNP combinationwere calculated with the adap-
tive perm option of PLINK (aperm), permuting up to 1 billion
replicates (EMP p value). This corrects for possible nonnormality
of the phenotype distribution. Permutations correcting for
multiple testing within a cis region or whole-genome scan were
also performed with the max (T) permutation (mperm) option of
PLINK (region-wide p for cis; genome-wide p for trans). For each
phenotype, results were permuted 1000 times, with the same
seed to maintain the correlation between phenotypes. To estimate
phenotype-wide signiﬁcance (in addition to region-wide signiﬁ-
cance), the best statistic per replicate for each phenotype was
saved with the PLINK mperm-save option. Statbest, the statistic
from the most signiﬁcant phenotype, was deﬁned for each repli-
cate. Phenotype-wide corrected p values were calculated as
(Rþ1)/(Nþ1) where R is the number of times the statbest exceeded
the observed statistic and N is the number of permutations (1000).cis- and trans-Regulation of Methylation
Like the classiﬁcation of gene expression regulators, the regulation
of methylation traits can be roughly divided into two types: cis-
acting regulation by DNA elements in or adjacent to each CpG
site, and trans-acting regulation by factors from the genomic
regions distant from the CpG sites, including from different chro-
mosomes. We deﬁned the SNPs within a region bounded by 1 Mb
distance from both ends of each CpG site as candidates for cis anal-
ysis. All the other SNPs were analyzed for trans-acting associations
for each CpG site.Effect of mSNPs on Gene Expression
We tested the association of corresponding gene expression and
mSNPs (SNPs showing phenotype-wide signiﬁcant associations
with DNA methylation of CpG sites in a given gene) by linear
regression with PLINK. Region-wide signiﬁcance was corrected
for the number of SNPs analyzed for each expression probe (for
details, see above QTL analysis). Note that there were only a smallThe Amerinumber of individuals and genes with existing acceptable expres-
sion data, as described above.Correlation Analysis of DNA Methylation and Gene
Expression
We investigated the correlation between genetically determined
DNA methylation, which showed phenotype-wide signiﬁcant
cis-mQTL association and expression of the corresponding genes.
Pearson linear regression was applied to detect the correlation
between DNA methylation and gene expression by R after prepro-
cessingof expressionandmethylationdata (seeabove). Themultiple
testing correction of p values was performed by positive false
discovery rate (q value) implemented in Partek Genomics Suite.23Results
mQTL Analysis
In the cis analysis, 12,117 SNP-CpG pairs, consisting of
9,448 SNPs and 2,046 CpG sites (of 1,795 genes), were
signiﬁcantly correlated (region-wide permuted p % 0.05)
(Table S5). The associations of 3,323 pairs (involving 736
CpG sites of 658 genes associated with 2,878 SNPs)
remained signiﬁcant after correcting for the 8,590 methyl-
ation phenotypes tested (phenotype-wide p value% 0.05).
Among the 736 CpG sites with phenotype-wide signiﬁcant
cis associations, CpG sites within CGIs were more likely to
have phenotype-wide signiﬁcant cis-mQTLs than in non-
CGI regions (permutation p value ¼ 3.0E-4) (Table S6).
The cis associations with methylation showed effect
sizes (R2) ranging from 0.17 to 0.73. The most signiﬁcant
association for each of the CpG sites are shown in
Table 1 (top 10 probes with the smallest Wald p value)
and Table S7 (highlighted in orange for the 736 CpG sites
with phenotype-wide signiﬁcant cis-mQTL associations).
All SNPs that have region-wide signiﬁcant associations
with DNA methylation are in Table S5. Closer inspection
on the positions of SNPs with phenotype-wide signiﬁcant
cis-mQTL associations (Figure 1) showed that most of the
associated SNPs were near the CpG sites, 95% within
a 149 kb range.
390 SNPs showed cis association (phenotype-wide p %
0.05) with two or more CpG sites of 141 genes. Interest-
ingly, 163 SNPs’ and 85 genes’ CpG sites are clustered in
37 genomic regions (Table S8). In each cluster, multiple
SNPs are associated with multiple CpG sites of several
different genes. For example, a 186 Kb region on chromo-
some 1 contains 14 SNPs that are associated with three
CpG sites of three different genes (LCE1D [MIM 612606],
LCE2B [MIM 612610], and LCE3A [MIM 612613]). Gene
families were frequently observed in these clusters,
including keratin-associated protein, claudin, killer cell lec-
tin-like receptor, proline-rich protein BstNI subfamily, late
corniﬁed envelope protein, and other gene families. These
genes in one cluster are likely to be coregulated for their
DNA methylation.
In the trans analysis, 372 SNP-CpG pairs involving 368
SNPs and 246 CpG sites (of 240 genes) showed associationcan Journal of Human Genetics 86, 411–419, March 12, 2010 413
















cg24920358 PPIE rs1046988 1 39991652 1.21 0.73 1.32E-44 <1.00E-09 <0.001 <0.001
cg22333868 SYT1 rs1880867 12 78121579 1.22 0.73 2.09E-44 <1.00E-09 <0.001 <0.001
cg13926569 PAPSS2 rs2180968 10 89408710 1.21 0.72 1.25E-43 <1.00E-09 <0.001 <0.001
cg17749961 LYCAT rs829584 2 30530779 1.37 0.71 5.79E-43 <1.00E-09 <0.001 <0.001
cg10106388 CD244 rs12036670 1 159099485 1.39 0.71 9.59E-43 <1.00E-09 <0.001 <0.001
cg06873352 LYK5 rs2044125 17 59216916 1.16 0.71 3.38E-42 <1.00E-09 <0.001 <0.001
cg13507326 FLJ25976 rs2284235 14 77233176 1.25 0.70 2.07E-41 <1.00E-09 <0.001 <0.001
cg01561916 HAAO rs7583085 2 42876472 1.33 0.70 4.02E-41 <1.00E-09 <0.001 <0.001
cg14141399 HAS1 rs11672222 19 56919728 1.26 0.69 1.12E-40 <1.00E-09 <0.001 <0.001
cg18294158 ORC5L rs4461829 7 103657263 1.32 0.69 2.13E-40 <1.00E-09 <0.001 <0.001
Abbreviations: CpG, the CpG site as named by Illumina; gene symbol, the gene contains the CpG site; best correlated SNP, the SNP that shows themost significant
cis association with this CpG site; chr, the chromosome where the SNP is located; BETA, regression coefficient; R2, Regression r-squared; Wald p value, Wald test
asymptotic p value; EMP p value, empirical p value based on adaptive permutations, permuting up to 100 million replicates, in PLINK software. Region-wide
p value, empirical p value based on 103 permutations with correction for the number of SNPs tested for cis associations at this CpG site. Phenotype-wide p value,
empirical p value based on 103 permutations, correcting for the number of SNPs tested for cis associations of this CpG site and the number of CpG sites (pheno-
types) studied.at permutation corrected genome-wide p % 0.05
(Table S9). Thirty-eight SNP-CpG trans pairs (12 CpG sites
and 38 SNPs) were signiﬁcant after further phenotype-
wide correction (corrected p% 0.05, highlighted in orange
in Table S9). Table 2 showed the strongest trans associa-
tions of each CpG site. Ten of the trans associations have
SNPs from different chromosomes, while two are on the
same chromosomes but more than 1 Mb away from the
target CpG sites.Validation
In order to validate the DNA methylation measurement
obtained from the microarray, we successfully designed
pyrosequencing assays for ﬁve randomly selected cis-
mQTL CpG sites. Each CpG site was processed in one batch
for all samples, so no batch effect was involved. SVA is not
applicable to analysis of a few CpG sites. Linear regression
analysis was performed for the SNP that showed the best
signal with a given CpG site measured by pyrosequencing
without adjustment of covariates (see Table S10). Corre-
spondingly, the association was recalculated with residuals
of DNAmethylation measured by Illumina Beadchips after
correction for batch effect by COMBAT but no further pro-
cessing of SVA. All ﬁve cis associations detected with Illu-
mina Beadchip were conﬁrmed by data from pyrosequenc-
ing. One example is shown in Figure 2. Minor allele T of
rs10492813 signiﬁcantly increased DNA methylation of
cg23815491 (gray boxplot). Pyrosequencing validated the
association predicted by the Beadchip data (white box-
plot). We also examined the genotype clusters for the ﬁve
SNPs associated with DNA methylation of the ﬁve pyrose-
quencing-validated CpG sites (see Figure S7). The genotype
clusters were all of good quality.414 The American Journal of Human Genetics 86, 411–419, March 1Functional Effects of SNPs and DNA Methylation
on Gene Expression
The known relationships between SNPs and DNA methyl-
ation and between DNA methylation and gene expression
raised the question of whether SNPs associated with
mQTLs might also be associated with expression of the
same genes. Therefore, we further analyzed the association
of mSNPs (phenotype-wide signiﬁcantly associated with
DNA methylation in a cis manner mentioned above)
with gene expression of a given gene for which we had
existing data with acceptable quality. We identiﬁed 85
genes related to phenotype-wide signiﬁcant cis-mQTL
and with an expression probe that met QC criteria (greater
than 80% present, see Material and Methods above). These
SNPs, methylation, and expression data make up 112 CpG-
expression probe pairs (comprising101 CpG sites and 95
expression probes) and 550 mSNP-expression probe pairs
(comprising 447 mSNPs and 95 expression probes). We
looked at the relationships between these data pairs in
two ways: (1) association between genotypes of mSNPs
with gene expression and (2) correlation between methyl-
ation and gene expression.
Ninety-two of the 550 mSNP-expression probe pairs
(comprising 59 mSNPs and 19 expression probes of
17 genes) showed a region-wide signiﬁcant association
between the mSNP genotypes and the expression of the
corresponding gene (Table S12).
Twenty of the 112 CpG-expression probe pairs (com-
prising 19 CpG sites and 18 expression probes of 17 genes)
showed nominally signiﬁcant correlations. As expected,
DNA methylation negatively correlated with gene expres-
sion for 15 pairs, a majority of the pairs. Interestingly,
ﬁve pairs of four genes (ZNF266 [MIM 604751], FANCG
[MIM 607139], DDT [MIM 602750], and FUT1 [MIM2, 2010
Figure 1. p Values and Distances between CpG Sites and SNPs
cis SNPs are plotted by their relative distance fromCpG sites on the
horizontal axis and genotype-methylation association p values on
the vertical axis. The y axis is -log10 transformed permutation
p values of associations between cis SNPs and DNA methylation
(109 permutations). Red dots represent phenotype-wide signiﬁ-
cant cis associations and green triangles mean region-wide signif-
icance. The box plot shows the summary statistics of distance at
x axis. For the box plot, the right end is the lowest point within
1.5 interquartile (distance between third and ﬁrst quartile) from
the lower quartile, and the left end is the highest point within
1.5 interquartile of the upper quartile, the top of the box is the
upper or third quartile, the bottom of the box is lower or ﬁrst quar-
tile, the middle bar is median value, and the circles are possible
outliers. The median value of distance between cis SNPs and
CpG sites is 34.38 kb. Plot and box plot were created in R.211100]) showed that increased DNAmethylation upregu-
lated the genes’ expression. Eleven of the 20 pairs (11 CpG
sites of 10 genes and 10 expression probes of 10 genes)
survive multiple test correction (FDR q value % 0.05; see
Table 3).
Putting the above two correlations with the mQTL data
together, we noticed that 10 genes (involving 10 CpG sites,
11 expression probes, and 29 SNPs) showed three-way
associations—the same SNP simultaneously showed a
signiﬁcant association with DNA methylation and with
gene expression. At the same time, DNA methylation
signiﬁcantly correlated with gene expression of the same
gene (Table S13). For example, minor allele C of SNP
rs2235375 was associated with the increased methylation
level of gene IRF6 (MIM 607199) (CpG site cg23283495,
phenotype-wide p value < 0.001). The C allele was also
associated with the reduced expression of IRF6 with
region-wide signiﬁcance (region-wide p% 0.05). A signiﬁ-
cant linear negative correlation between methylation andThe Ameriexpression of gene IRF6 was observed. The box plot of
expression and methylation in gene IRF6 with SNP
rs2235375 is presented in Figure 3. The other nine
‘‘three-way associations’’ are showed in Figure S8.Discussion
We have observed that numerous CpG sites are regulated
by genetic variants in cis and/or trans manner. Our results
showed that CpG sites with extensive variability were
more enriched in non-CGI (CpG islands) regions than
within CGIs. Previous studies found that CpG sites in
CGI were largely unmethylated,17,18 whereas CpG sites in
non-CGI regions were moderately to highly methylated.16
Interestingly, CpG sites within CGIs were more likely to be
phenotype-wide signiﬁcantly associated with cis regulators
than in non-CGI regions (permutation p value ¼ 3.0E-4).
The fact that genetic variants regulate DNA methylation
of CGIs more than of CpG island shores and distant CpG
sites is intriguing in light of the report by Irizarry et al.19
They reported that CpG island shores are enriched for
tissue-speciﬁc methylation sites in a study comparing
different tissue types.19
Our ﬁndings are concordant with the ﬁndings of a
number of previous studies associating variation of candi-
date gene DNAmethylation with SNPs in cis in human and
mice.6,9,24 Kerkel et al. carried out a pioneering genome-
wide survey of ASM sites.9 They found 16 sites with
ASM. Eight of the 16 sites (around BCL2 [MIM 151430],
CYP2A7 [MIM 608054], EFNB1 [MIM 300035], GCNT3
[MIM 606836], LTF [MIM 150210], PIM1 [MIM 164960],
VNN1 [MIM 603570], and MAGEL2 [MIM 605283] genes)
reported by Kerkel et al. gave at least nominally signiﬁcant
associations in our cis association study, even though the
Kerkel et al. group studied tissues other than brain. Only
the LTF cis association reached phenotype-wide signiﬁ-
cance in our study. Differences between the two studies
might be attributable to tissue differences and to different
statistical criteria for signiﬁcance.
Kerkel et al.’s ﬁndings were probably limited to SNPs
within 2 kb regions around the CpG sites, because their
detection relied on short amplicons after HpaII or MspI
digestion. Our association tests capture longer-distance
SNP-methylation correlations: cis associations extend to
SNPs within 1 Mb distance on each side of the CpG site.
Most of our cis phenotype-wide signiﬁcant associations
(87.9%) are from regions more than 2 kb away from the
CpG sites. In a few cases, effectswere observable over longer
distances, which were probably out of the range of linkage
disequilibrium (LD) because the average r2 (r: correlation
coefﬁcient between pairs of loci, a measure of LD) for SNP
pairs decreases to less than 0.1 when the distance interval
is 160 kb in Europeans.25 trans association of DNAmethyl-
ation largely came from different chromosomes.
DNA methylation of IGF2/H19, one of the best-charac-
terized genetically regulated loci, was previously reportedcan Journal of Human Genetics 86, 411–419, March 12, 2010 415


























cg18540325 9 33785118 PRSS3 rs2855981 7 142176424 N/A 1.19 3.66E-43 <0.001 <0.001
cg17704839 19 9800038 UBL5 rs9902253 17 27573486 RHOT1 1.54 2.43E-30 <0.001 <0.001
cg13055278 2 8739739 ID2 rs11917047 3 62081519 PTPRG 1.19 4.29E-28 <0.001 <0.001
cg10237469 19 46825249 CEACAM4 rs10407775 19 47837257 CEACAM8 1.47 1.25E-24 <0.001 <0.001
cg26922202 9 35947984 OR2S2 rs10939605 4 9505391 SLC2A9 1.06 8.89E-23 <0.001 <0.001
cg12218747 21 36373536 SETD4 rs7248584 19 43949950 LGALS7B 0.97 1.95E-20 <0.001 <0.001
cg18806365 8 82355364 FABP5 rs17552971 15 83772939 N/A 0.95 6.15E-20 <0.001 <0.001
cg00984602 6 43247670 SRF rs7643223 3 165208927 SILV 0.88 1.07E-17 <0.001 <0.001
cg13033054 21 32870432 C21orf77 rs3010556 6 167670167 TTLL2 0.79 1.10E-13 <0.001 <0.001
cg25239996 20 44180174 CD40 rs7250371 19 62552897 ZNF543 0.73 2.48E-12 <0.001 <0.001
cg03923277 12 102883862 TDG rs551601 12 124376911 AACS 0.89 2.72E-15 <0.001 0.045
cg11235426 6 237522 DUSP22 rs12933929 16 34969086 N/A 0.78 2.55E-14 <0.001 0.05
Abbreviations: CpG, the CpG site as named by Illumina; CpG Chr. and CpG position denote the physical location of each CpG site; gene symbol (CpG), the gene
that contains the CpG site; best-correlated SNP, the SNP that shows the most significant trans association with methylation of the CpG; SNP Chr., the chromo-
somewhere the SNP is located; gene symbol (SNP), the gene where the trans-SNP locates; beta, regression coefficient; Wald p value, Wald test asymptotic p value;
genome-wide p value, empirical p value based on 103 permutations with correction for the number of SNPs tested for trans associations of this CpG site. Pheno-
type-wide p value, empirical p value based on 103 permutations, correcting for the number of SNPs tested for trans associations of this CpG site and the number of
CpG sites (phenotypes) studied. N/A means that there is no known gene near this SNP.to be strongly determined by heritable factors and SNPs in
cis.6 Our analysis conﬁrmed cis association in IGF2/H19Figure 2. Methylation of cg23815491 Measured by Pyrose-
quencing and Beadchip Associated with SNP rs10492831
DNA methylation of cg23815491 measured by Illumina Beadchip
(right) and pyrosequencing (left). DNA methylation was plotted
against the genotypes of rs10492813. The x axis has three geno-
types of rs10492813, and y axis was the raw data measured DNA
methylation by pyrosequening and Illumina Beadchips. Minor
allele Tof rs10492813 is signiﬁcantly associated with highmethyl-
ation level of cg23825491 in a cis manner assessed by Beadchip
(Wald p value ¼ 1.02E-46). The same trend was observed in pyro-
sequencing data (Wald p value ¼ 1.50E-56). The correlation coef-
ﬁcient between the two methods was r ¼ 0.91. For each box
plot, the top bar is the lowest point within 1.5 interquartile from
the lower quartile, and the left end is the highest point within
1.5 interquartile of the upper quartile, the top of box is the upper
or third quartile, the bottomof box is the lower or ﬁrst quartile, the
middle bar is the median value, and circles are possible outliers.
416 The American Journal of Human Genetics 86, 411–419, March 1(region-wide p < 0.05), although the SNP that showed
the most signiﬁcant association in a previous study was
not included in this study and the association in this study
did not reach our strict phenotype-wide signiﬁcance level.
Several known genes (such as DNMT1 [MIM 126375],
DNMT3A [MIM 602769], DNMT3B [MIM 602900],MTHFR
[MIM 607093], etc.) are involved in general DNA methyla-
tion. Dnmt3a and Dnmt3b are required for de novo meth-
ylation of DNA in mammals.26–28 Dnmt1 is known to
have a high preference for hemimethylated CpG sites
and has an important role in maintenance of methyla-
tion.29,30 MTHFR affects global DNA methylation.31
None of these genes contain SNPs signiﬁcantly associated
with mQTLs in the present study. Heijmans and colleagues
also failed to detect an association of MTHFR with DNA
methylation of IGF2/H19.6 One possible reason is that
the polymorphisms in these genes are not completely
covered in our study and in Heijmans et al.’s study (for
list of SNPs tested in this study, see Table S11). Another
more likely explanation is that the current study identiﬁes
gene-speciﬁc DNA methylation, which is different from
the global DNA methylation controlled by these known
methylation pathway genes. The current results may even-
tually contribute to an understanding of the mechanisms
of gene-speciﬁc DNA methylation.
By using available and acceptable quality gene expres-
sion data, we further found that about 13% (59/447) of
genetic variants regulating DNA methylation (mSNPs)
also affect gene expression. Around 18% (20/112) of
CpG-expression probe pairs showed nominally signiﬁcant
correlations. Increased DNA methylation upregulated the2, 2010
Table 3. Most Significant Correlations of Methylation with Phenotype-wide Significant cis Regulators and Expression
Probe CpG Gene Symbol r p value FDR q value Chr. Position Distance
32730_at cg00186701 TSPYL5 0.62 5.63E-06 3.00E-04 8 98359686 334
41619_at cg23283495 IRF6 0.61 8.88E-06 3.00E-04 1 208046402 300
39310_at cg24010952 BDKRB2 0.60 1.26E-05 3.00E-04 14 95740615 335
40936_at cg00850538 CRIM1 0.58 3.25E-05 5.80E-04 2 36435542 1359
1596_g_at cg09827833 TEK 0.54 1.12E-04 1.60E-03 9 27099492 51
34193_at cg00903242 CHL1 0.51 3.38E-04 4.02E-03 3 213161 489
37222_at cg24330042 GSTT1 0.48 8.28E-04 8.45E-03 22 22714159 72
1596_g_at cg04995717 TEK 0.47 1.25E-03 0.012 9 27099293 148
37902_at cg09142399 CRYZ 0.45 1.78E-03 0.014 1 74972682 1367
38241_at cg01269795 BTN3A3 0.39 7.73E-03 0.050 6 26548080 662
751_at cg08587864 PIGC 0.39 7.26E-03 0.050 1 170680235 382
374_f_at cg04394102 DDT 0.38 9.53E-03 0.056 22 22651863 156
40337_at cg13881341 FUT1 0.38 1.08E-02 0.059 19 53951027 568
33412_at cg19853760 LGALS1 0.37 1.26E-02 0.064 22 36401623 34
38241_at cg25193278 BTN3A3 0.36 1.66E-02 0.079 6 26548763 21
40578_s_at cg14414534 TMOD1 0.33 2.54E-02 0.11 9 99326304 46
41621_i_at cg21116314 ZNF266 0.31 3.64E-02 0.15 19 9407752 518
37584_at cg05293216 FANCG 0.31 4.10E-02 0.16 9 35070812 799
33689_s_at cg04394102 DDT 0.30 4.87E-02 0.16 22 22651863 156
Abbreviations: Probe, the probes of gene expression study; CpG, the CpG site as named by Illumina; r, Pearson correlation coefficient; p value, p value for linear
regression; FDR q value, corrected for multiple tests by FDR; Chr., the chromosome where the gene and CpG site is located; Position, the location of CpG site;
Distance, distance of CpG site to transcription start site. Gene symbol indicates the gene of the CpG site. Top 11 correlations have FDR q% 0.05.gene’s expression for ﬁve CpG-probe pairs of four genes.
Previous studies have also reported positive correlations
between DNA methylation of gene body and gene expres-Figure 3. DNAMethylation and Gene Expression of IRF6 Plotted
by Genotypes of rs2235375
DNA methylation (left) and gene expression (right) of IRF6 is
correlated with genotypes of rs2235375. The x axis has three geno-
types of rs2235375, and y axis displays post-SVAþCOMBAT resid-
uals representing DNA methylation and gene expression levels.
Minor allele C of rs2235375 is signiﬁcantly associated with high
methylation level of IRF6 in a cismanner and simultaneously asso-
ciated with low gene expression of IRF6.
The Amerision.32–34 Further studies are needed to explore the mech-
anism of hypomethylation and decreased gene expression.
Taking SNP, DNA methylation, and gene expression
together, we observed 10 genes that showed three-way
associations. In the case of rs2235375, the C allele was
simultaneously associated with increased methylation
and decreased expression of IRF6. SNP rs2235375 is an in-
tronic polymorphism located 14 kb away from the studied
promoter CpG site. This ﬁnding strongly implicates a
distant intronic variation affecting DNA methylation,
whichmay then impact expression of the gene itself. Inter-
estingly, the C allele of SNP rs2235375 has been associated
with nonsyndromic cleft lip with or without cleft palate.35
In addition, Irf6 knockout mice developed abnormal skin,
limb, and craniofacial morphogenesis.36 DNAmethylation
regulation disturbance and consequential reduction in
gene expression could be an explanation of the genetic
association detected in the cleft lip study.
These associations imply that mQTLs and eQTLs of
particular genes may be related but not identical. Similarly,
Kerkel et al.’s study reported that two out of four genes
tested showed both allelic expression and allelic methyla-
tion.9 Of course, many other factors are involved in regu-
lating gene expression besides DNA methylation and
SNPs. The contribution of genetic variants and DNAmeth-
ylation to gene expression varies gene by gene. Studies ofcan Journal of Human Genetics 86, 411–419, March 12, 2010 417
both mQTLs and eQTLs can illuminate the potential func-
tional role of genetic variations in association studies of
complex disease.
Our results reveal numerous new instances of genetic
variability contributing to the variability of DNA methyla-
tion of speciﬁc genomic regions. In recent years, genome-
wide association has revealed many SNPs associated with
diseases or other phenotypes. In addition to effects on
protein coding, RNA splicing, and microRNA targeting,
the impact of genetic factors on DNA methylation is
clearly another important aspect to study in the evaluation
of SNP functional effects. The interactions between SNPs
and target CpG sites, particularly in those related to trans
signals, may lead to identiﬁcation of novel gene-gene
interactions. These ﬁndings could lead to the discovery
of novel mechanisms that determine gene-speciﬁc DNA
methylation, which has functional effects on phenotypes
including disease.
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